A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a
Clinical trial NCT00117013 · COMPLETED
Trial details
- NCT number
- NCT00117013
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-28
- Primary completion
- 2010-10-25
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.